Clarithromycin added to Bortezomib-Cyclophosphamide-Dexamethasone impairs health-related quality of life in multiple myeloma patients

Lene Kongsgaard Nielsen, Tobias Wirenfeldt Klausen, Mary Jarden, Henrik Frederiksen, Annette Juul Vangsted, Trung Do, Ida Bruun Kristensen, Ulf Christian Frølund, Christen Lykkegaard Andersen, Niels Abildgaard, Henrik Gregersen

Research output: Contribution to journalJournal articleResearchpeer-review

2 Citations (Scopus)
128 Downloads (Pure)
Original languageEnglish
JournalEuropean Journal of Haematology
Volume102
Issue number1
Pages (from-to)70-78
Number of pages9
ISSN0902-4441
DOIs
Publication statusPublished - Jan 2019

Bibliographical note

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Keywords

  • clinical trials
  • multiple myeloma
  • quality of life
  • transplantation

Fingerprint Dive into the research topics of 'Clarithromycin added to Bortezomib-Cyclophosphamide-Dexamethasone impairs health-related quality of life in multiple myeloma patients'. Together they form a unique fingerprint.

Cite this